• Cepheid, Oxford Nanopore Expand Partnership, Revvity Launches New Platform, More

    Bio-IT World | The first quantum genome; Cepheid and Oxford Nanopore expand their partnership; Revvity launch Signals BioDesign; PathAI and MedStar Health enter multi-year strategic collaboration; and more.

    Apr 28, 2026

  • fMRI-Based Mega-Study of Psychedelics Reveals Patterns of Brain Signaling Reorganization

    Bio-IT World | Psychedelics are receiving increased attention for their potential to treat various mental health conditions. Just this week, an executive order was signed directing the United States FDA, DEA, and HHS to facilitate, fund, and fast track clinical research and review of psychedelics.

    Apr 23, 2026

  • From Brain Implant to Lifelong Companion: Michel Maharbiz Unveils Epia Neuro

    Bio-IT World | Michel Maharbiz walked to the podium with an announcement and an apology. After years of incessant investor pitching in private, Maharbiz said, this was the first time he’d be speaking about the venture openly. What followed was part company reveal, part field critique, part vision statement and a pitch for nothing less than a new paradigm for how brain-computer interfaces are built, deployed, and kept alive in patients’ bodies over a lifetime.

    Apr 22, 2026

  • Investors Sound Off on BCI Hype, Regulatory Risk, and the AI Gold Rush

    Bio-IT World | JoJo Platt of Neurotech Reports opened her panel at the 2026 Bioelectronic Medicine Forum with her own notebook open. She has an upcoming appointment to talk to Congress about brain-computer interfaces, and she wanted her panel of investors to weigh in. They didn’t hesitate: the need for regulatory sandboxes, clearer reimbursement pathways, freedom from regulation burden, and more translational grant funding.

    Apr 21, 2026

  • SPT Labtech and EMBL GeneCore Team Up for Fully Walkaway Automated Genomics Workflows

    Bio-IT World | SPT Labtech and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore) have entered a collaborative partnership to advance fully walkaway automated genomics workflows.

    Apr 16, 2026

  • AWS Launches Agentic Drug Discovery-Wet Lab Pipeline

    Bio-IT World | AWS this week announced Amazon Bio Discovery, a new AI-powered application designed to help scientists design novel drugs quickly and send them to wet lab partners for synthesizing and testing.

    Apr 15, 2026